NovoCare introductory pricing ($199/mo) for new patients through June 2026, starter doses only
Today, GLP-1 weight loss therapy is an FDA-approved category, entirely separate from diabetes management
Fruit and vegetable consumption and prospective weight change in participants of the European Prospective Investigation into Cancer and Nutrition-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating Out of Home, and Obesity study
(Weight Loss) Tirzepatide References 1
Book your consultation today and start seeing real weight loss results
According to KHIDIs 2025 Medical Tourism Survey, 41.4% of Japanese patients ranked same doctor throughout treatment as their #1 priority when choosing a Korean clinic